Novo-Nordisk A/S (NVO)
NYSE
$38.80+$0.1800 (+0.47%) on the dayAs of the close; data may be delayed.
NVO price, last 12 months
Key stats
- Previous close
- $38.62
- Open
- $38.59
- Day range
- $38.41 – $38.88
- 52-week range
- $35.12 – $64.16
- Volume
- 9.4M
- Avg volume (20 days)
- 13.2M
- Market cap
- $171.4B
Performance
1W−10.3%
1M−17.8%
3M−19.3%
6M+6.6%
YTD−23.7%
1Y−34.0%
vs S&P 500, 1Y−50.7 pts
Technicals and fundamentals
About Novo-Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
- Listed on
- NYSE
- Market cap
- $171.4B